Author

Nicolau Vallejo-Senra

ACCURACY OF FIB-4 AND HEPAMET FIBROSIS SCORE TO IDENTIFY ADVANCED LIVER FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
ACCURACY OF FIB-4 AND HEPAMET FIBROSIS SCORE TO IDENTIFY ADVANCED LIVER FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

PREVALENCE AND RISK FACTORS ASSOCIATED WITH PROGRESSION TO ADVANCED FIBROSIS AND CIRRHOSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): ANALYSIS OF A PROSPECTIVE REGISTRY
PREVALENCE AND RISK FACTORS ASSOCIATED WITH PROGRESSION TO ADVANCED FIBROSIS AND CIRRHOSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): ANALYSIS OF A PROSPECTIVE REGISTRY

DISTINCTIVE CLINICAL FEATURES OF NON-ALCOHOLIC AND MIXED FATTY LIVER DISEASE
DISTINCTIVE CLINICAL FEATURES OF NON-ALCOHOLIC AND MIXED FATTY LIVER DISEASE

Nicolau Vallejo-Senra  et al.

DISTINCTIVE CLINICAL FEATURES OF NON-ALCOHOLIC AND MIXED FATTY LIVER DISEASE
DISTINCTIVE CLINICAL FEATURES OF NON-ALCOHOLIC AND MIXED FATTY LIVER DISEASE

PREVALENCE AND RISK FACTORS ASSOCIATED WITH PROGRESSION TO ADVANCED FIBROSIS AND CIRRHOSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): ANALYSIS OF A PROSPECTIVE REGISTRY
PREVALENCE AND RISK FACTORS ASSOCIATED WITH PROGRESSION TO ADVANCED FIBROSIS AND CIRRHOSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): ANALYSIS OF A PROSPECTIVE REGISTRY

Nicolau Vallejo-Senra  et al.

ACCURACY OF FIB-4 AND HEPAMET FIBROSIS SCORE TO IDENTIFY ADVANCED LIVER FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
ACCURACY OF FIB-4 AND HEPAMET FIBROSIS SCORE TO IDENTIFY ADVANCED LIVER FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

Nicolau Vallejo-Senra  et al.

Item 1 - 6 / 6
1